AC Immune SA (NASDAQ:ACIU)
| 2.31 Delayed Data As of Jun 06 |  -0.06 / -2.53%Today’s Change | 1.68 Today|||52-Week Range 3.90 | +13.24% Year-to-Date |
Latest ACIU News | Press Releases
No recent news for AC Immune SA.
Today’s Trading
| Previous close | 2.37 |
| Today’s open | 2.34 |
| Day’s range | 2.28 - 2.35 |
| Volume | 842 |
| Average volume (3 months) | 110,134 |
| Market cap | $185.6M |
Data as of 3:59pm ET, 06/06/2023
Growth & Valuation
| Earnings growth (last year) | +16.77% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 41.37 |
| Price/Book | 1.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AADIAadi Bioscience Inc | +0.05 | +0.62% |
| --China Health Group I... | 0.00 | 0.00% |
| GRTSGritstone bio Inc | +0.17 | +7.69% |
| PDSBPDS Biotechnology Co... | -0.32 | -4.90% |
Data as of 3:59pm ET, 06/06/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $4.1M |
| Annual profit (last year) | -$74.1M |
| Net profit margin | -1,798.04% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Lausanne, Vaud |
Forecasts
